Worth Watching Stocks: HP Inc. (HPQ), The Charles Schwab Corporation (SCHW), Rennova Health, Inc. (RNVA)

HP Inc. (HPQ) saw its value decrease by 0% as the stock dropped $0 to finish the day at a closing price of $14.58. The stock was higher in trading and has fluctuated between $8.91-$16.25 per share for the past year. The shares, which traded within a range of $14.5 to $14.7 during the day, are up by 4.8% in the past three months and up by 5.58% over the past six months. It is currently trading -2.48% below its 20 day moving average and -4.26% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $16.1 a share over the next twelve months. The current relative strength index (RSI) reading is 36.64.The technical indicator lead us to believe there will be no major movement any time soon, hold.

HP Inc. provides products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses, as well as to the government, health, and education sectors worldwide. It operates through Personal Systems and Printing segments. The Personal Systems segment offers commercial personal computers (PCs), consumer PCs, workstations, thin clients, commercial tablets and mobility devices, retail point-of-sale systems, displays and other related accessories, software, support, and services for the commercial and consumer markets. The Printing segment provides consumer and commercial printer hardware, supplies, media, solutions, and services, as well as scanning devices; and laserjet and enterprise, inkjet and printing, graphics, and 3D printing solutions. The company was formerly known as Hewlett-Packard Company and changed its name to HP Inc. in October 2015. HP Inc. was founded in 1939 and is headquartered in Palo Alto, California.

The Charles Schwab Corporation (SCHW) shares were up in last trading by 1.91% to $41.1. It experienced higher than average volume on day. The stock decreased in value by almost -0.22% over the past week and grew 4.26% in the past month. It is currently trading 6.74% above its 50 day moving average and 30.25% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -1.79% decrease in value from its one year high of $41.85. The RSI indicator value of 60.2, lead us to believe that it is a hold for now.

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; and stock plan services, compliance solutions, and mutual fund clearing services, as well as engages in the off-platform sales business. The Advisor Services segment provides custodial, trading, and support services; and retirement and corporate brokerage retirement services. The company provides brokerage accounts with cash management capabilities; third-party mutual funds through the Mutual Fund Marketplace, including no-transaction fee mutual funds through the Mutual Fund OneSource service, which includes proprietary mutual funds, plus mutual fund trading, and clearing services to broker-dealers; exchange-traded funds (ETFs), including proprietary and third-party ETFs; and advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. It also offers banking products and services, including checking and savings accounts, certificates of deposit, first lien residential real estate mortgage loans, home equity loans and lines of credit, and Pledged Asset Lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. The company serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

Rennova Health, Inc. (RNVA) traded within a range of $0.09 to $0.1 after opening the day at $0.1. The company has seen its stock increase in value by 8.43% so far this year. The stock was down close to -6.74% on active volume in last trading session and closed at $0.09 per share. After the recent fall, the stock is currently holding -92.24% below its 52 week high of $1.16 and 12.5% above its 12-month low of $0.08. The shares are down by over -43.75% in the last three months, and the RSI indicator value of 48.14 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers in the United States. It offers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management solutions, as well as intends to provide financial services in the form of loans to physician practices. The company provides toxicology, clinical pharmacogenetics, and esoteric testing services; develops Web-based system to place lab orders, track samples, and view test reports in real time; Web-enabled laboratory information management solutions; Medical Mime, which offers an electronic health record for substance abuse and behavioral health providers; and CollabRx that enhances cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients. Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida.

 

Stock’s Trend Analysis Report: The Charles Schwab Corporation (SCHW), Oracle Corporation (ORCL), NRG Energy, Inc. (NRG)

The Charles Schwab Corporation (SCHW) fell -2.61% during last trading as the stock lost $-1.08 to finish the day at $40.33 with about 11.11M shares changing hands, compared to its three month average trading volume of 9.24M. The $53.27B market cap company, which fluctuated between $40.26 and $41.33 during the day, currently situated 88.81% above its 52 week low of $21.51 and -3.63% away from its one year high of $41.85. The RSI of 52.91 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; and stock plan services, compliance solutions, and mutual fund clearing services, as well as engages in the off-platform sales business. The Advisor Services segment provides custodial, trading, and support services; and retirement and corporate brokerage retirement services. The company provides brokerage accounts with cash management capabilities; third-party mutual funds through the Mutual Fund Marketplace, including no-transaction fee mutual funds through the Mutual Fund OneSource service, which includes proprietary mutual funds, plus mutual fund trading, and clearing services to broker-dealers; exchange-traded funds (ETFs), including proprietary and third-party ETFs; and advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. It also offers banking products and services, including checking and savings accounts, certificates of deposit, first lien residential real estate mortgage loans, home equity loans and lines of credit, and Pledged Asset Lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. The company serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

Oracle Corporation (ORCL) dropped $-0.16 to close the day at a new closing price of $39.1, a -0.41% decrease in value from its previous closing price that moved the stock 19.82% above its 52 week low of $33.13. A total of 11.08M shares exchanged hands during the day compared with its three month average trading volume of 12.67M. The stock, which fluctuated between $38.88 and $39.28 during the day, currently situated -5.98% below its 52 week high. The stock is down by -3.98% in the past one month and up by 2.2% over the past three months. With a one year target estimate of $43.97 and RSI of 51.39, the stock still has upside potential, making it a hold for now.

Oracle Corporation develops, manufactures, markets, sells, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide. It offers services in three primary layers of the cloud: Software as a Service, Platform as a Service, and Infrastructure as a Service. The company licenses its Oracle Database software, which enables storage, retrieval, and manipulation of various forms of data; and Oracle Fusion Middleware software to build, deploy, secure, access, and integrate business applications, as well as automate their business processes. It also provides a range of software for mobile computing to address the development needs of businesses; and Java, a software development language. In addition, the company offers application software, such as human capital and talent management, customer experience and customer relationship management, financial management and governance, risk and compliance, procurement, project portfolio management, supply chain management, business analytics and enterprise performance management, and industry-specific application software. Further, it offers hardware systems products, such as Oracle Engineered Systems, servers, storage, networking, industry specific hardware, virtualization software, operating systems, management software, and related hardware services. Additionally, the company offers customers with rights to software product upgrades and maintenance releases, patches released, and Internet access to technical content, as well as Internet and telephone access to technical support personnel. The company also provides consulting services, such as IT strategy alignment, enterprise architecture planning and design, initial product implementation and integration, and ongoing product enhancement and upgrade; customer support services; and education services. Oracle Corporation was founded in 1977 and is headquartered in Redwood City, California.

NRG Energy, Inc. (NRG) had a light trading with around 10.92M shares changing hands compared to its three month average trading volume of 6.65M. The stock traded between $15.05 and $15.92 before closing at the price of $15.34 with 5.07% change on the day. The Princeton New Jersey 08540 based company is currently trading 75.76% above its 52 week low of $8.92 and -15.85% below its 52 week high of $18.32. Both the RSI indicator and target price of 80.88 and $16.25 respectively, lead us to believe that it could drop over the coming weeks.

NRG Energy, Inc., together with its subsidiaries, operates as a power company. The company provides electricity; system power, distributed generation, solar and wind products, backup generation, storage and distributed solar, demand response, energy efficiency, electric vehicle charging stations, and on-site energy solutions; carbon management and specialty services; and various energy services, such as operations, maintenance, technical, development, and asset management services. It owns and operates approximately 50,000 megawatts of generation. The company also offers retail energy, rooftop solar, portable solar, and battery products home services; and various bundled products, which combine energy with protection products, energy efficiency, and renewable energy solutions, as well as offers installation and contract management services for residential solar customers. As of December 31, 2015, it served approximately 2.77 million recurring and 624,000 discrete customers. In addition, the company owns, operates, and develops solar and wind power projects; develops, constructs, and finances a range of solutions for utilities, schools, municipalities, and commercial markets; and trades in electric power, natural gas, and related commodity and financial products, including forwards, futures, options, and swaps. As of December 31, 2015, it operated 90 active fossil fuel and nuclear plants, 16 utility scale solar facilities, and 36 wind farms and multiple distributed solar facilities. Further, the company transacts in and trades fuel and transportation services; directly sells energy, services, and products and services to retail customers under the NRG, Reliant, and other names; and provides steam, hot water, and chilled water, as well as electricity to commercial businesses, universities, hospitals, and governmental units. NRG Energy, Inc. was founded in 1989 and is headquartered in Princeton, New Jersey.

 

Stocks Under Consideration: The Charles Schwab Corporation (SCHW), Bristol-Myers Squibb Company (BMY), MannKind Corporation (MNKD)

The Charles Schwab Corporation (SCHW) grew with the stock adding 0.36% or $0.15 to close at $41.41 on light trading volume of 7.67M compared its three months average trading volume of 9.27M. The San Francisco California 94105 based company operating under the Investment Brokerage – National industry has been trending up for the last 52 weeks, with the shares price now 48.68% up for the period and up by 4.92% so far this year. With price target of $43.5 and a 93.87% rebound from 52-week low, The Charles Schwab Corporation has plenty of upside potential, making it a hold with a view buy.

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; and stock plan services, compliance solutions, and mutual fund clearing services, as well as engages in the off-platform sales business. The Advisor Services segment provides custodial, trading, and support services; and retirement and corporate brokerage retirement services. The company provides brokerage accounts with cash management capabilities; third-party mutual funds through the Mutual Fund Marketplace, including no-transaction fee mutual funds through the Mutual Fund OneSource service, which includes proprietary mutual funds, plus mutual fund trading, and clearing services to broker-dealers; exchange-traded funds (ETFs), including proprietary and third-party ETFs; and advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. It also offers banking products and services, including checking and savings accounts, certificates of deposit, first lien residential real estate mortgage loans, home equity loans and lines of credit, and Pledged Asset Lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. The company serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

Bristol-Myers Squibb Company (BMY) had a active trading with around 7.66M shares changing hands compared to its three month average trading volume of 10.3M. The stock traded between $56.05 and $56.73 before closing at the price of $56.22 with -0.58% change on the day. The New York New York 10154 based company is currently trading 15.42% above its 52 week low of $49.03 and -26.11% below its 52 week high of $77.12. Both the RSI indicator and target price of  and $62.53 respectively, lead us to believe that it could rise over the coming weeks.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. It offers chemically-synthesized drug or small molecule, and biologic in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; immunoscience; cardiovascular; and neuroscience. Its products include Baraclude for the treatment of chronic hepatitis B virus infection; Daklinza and Sunvepra for the treatment of hepatitis C virus infection; Reyataz and Sustiva for the treatment of HIV; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Opdivo, a fully human monoclonal antibody for non-small cell lung and renal cell cancer, and melanoma; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for metastatic melanoma; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Orencia to treat rheumatoid arthritis; and Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation. Its products pipeline includes Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; BMS-663068, an investigational compound that is being studied in HIV-1; and Prostvac, a Phase III prostate-specific antigen to treat asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. The company has clinical trial collaborations with Calithera Biosciences, Inc. and Janssen Biotech, Inc.; and a research collaboration with GeneCentric Diagnostics, Inc. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.

MannKind Corporation (MNKD) saw its value increase by 6.07% as the stock gained $0.04 to finish the day at a closing price of $0.69. The stock was higher in trading and has fluctuated between $0.41-$2.24 per share for the past year. The shares, which traded within a range of $0.6602 to $0.7226 during the day, are up by 22.64% in the past three months and down by -32.15% over the past six months. It is currently trading 2.46% above its 20 day moving average and 14.04% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $0 a share over the next twelve months. The current relative strength index (RSI) reading is 54.01.The technical indicator lead us to believe there will be no major movement any time soon, hold.

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. Its approved product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. MannKind Corporation has license and collaboration agreement with Sanofi-Aventis Deutschland GmbH for the development of AFREZZA. The company was founded in 1991 and is headquartered in Valencia, California.

 

Stocks on Trader’s Radar: Mast Therapeutics, Inc. (MSTX), Gilead Sciences Inc. (GILD), The Charles Schwab Corporation (SCHW)

Mast Therapeutics, Inc. (MSTX) continued its downward trend with the stock declining -5.54% or $-0.01 to close the day at $0.14 on light trading volume of 7.05M shares, compared to its three month average trading volume of 9.35M. The San Diego California 92130 based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -67.49%, compared to the industry which has advanced 3.08% over the same period. With RSI of 65.33, the stock should still continue to rise and get closer to its one year target estimate of $2.75, making it a hold for now.

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of heart failure with preserved ejection fraction. The company was formerly known as ADVENTRX Pharmaceuticals, Inc. and changed its name to Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

Gilead Sciences Inc. (GILD) fell -0.56% during last trading as the stock lost $-0.41 to finish the day at $73.36 with about 7.04M shares changing hands, compared to its three month average trading volume of 9.63M. The $97.31B market cap company, which fluctuated between $72.93 and $73.68 during the day, currently situated 4.24% above its 52 week low of $70.83 and -27.55% away from its one year high of $103.1. The RSI of 45.06 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The company’s products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions, as well as diabetic nephropathy and ebola. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.

The Charles Schwab Corporation (SCHW) saw its value decrease by -0.15% as the stock dropped $-0.06 to finish the day at a closing price of $41.26. The stock was lighter in trading and has fluctuated between $21.51-$41.52 per share for the past year. The shares, which traded within a range of $40.42 to $41.33 during the day, are up by 30.32% in the past three months and up by 53.96% over the past six months. It is currently trading 2.91% above its 20 day moving average and 8.78% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $41.33 a share over the next twelve months. The current relative strength index (RSI) reading is 66.83. The technical indicator lead us to believe there will be no major movement any time soon, hold.

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; and stock plan services, compliance solutions, and mutual fund clearing services, as well as engages in the off-platform sales business. The Advisor Services segment provides custodial, trading, and support services; and retirement and corporate brokerage retirement services. The company provides brokerage accounts with cash management capabilities; third-party mutual funds through the Mutual Fund Marketplace, including no-transaction fee mutual funds through the Mutual Fund OneSource service, which includes proprietary mutual funds, plus mutual fund trading, and clearing services to broker-dealers; exchange-traded funds (ETFs), including proprietary and third-party ETFs; and advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. It also offers banking products and services, including checking and savings accounts, certificates of deposit, first lien residential real estate mortgage loans, home equity loans and lines of credit, and Pledged Asset Lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. The company serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

 

Stocks in the Spotlight: Juniper Networks, Inc. (JNPR), Amgen Inc. (AMGN), The Charles Schwab Corporation (SCHW)

Juniper Networks, Inc. (JNPR) had a active trading with around 4.79M shares changing hands compared to its three month average trading volume of 4.35M. The stock traded between $27.32 and $27.94 before closing at the price of $27.85 with -1.94% change on the day. The Sunnyvale California 94089 based company is currently trading 32.56% above its 52 week low of $21.18 and -4.66% below its 52 week high of $29.21. Both the RSI indicator and target price of 48.09 and $28.29 respectively, lead us to believe that it should be put on hold over the coming weeks.

Juniper Networks, Inc. designs, develops, and sells network products and services worldwide. It offers various routing products, including ACX series universal access routers to deploy new high-bandwidth services; MX series Ethernet routers that functions as a universal edge platform; M series edge routers; PTX series packet transport routers; T series routers; and NorthStar controllers. The company also provides various switching products comprising EX series Ethernet switches to address the access, aggregation, and core layer switching requirements of micro branch, branch office, and campus and data center environments; QFX series of core, spine, and top-of-rack data center switches; and OCX1100, an open networking switch. In addition, it offers security products, such as SRX series services gateways for the data centers; Branch SRX family that includes SRX300 Series and SRX1500, which provides integrated firewall capabilities; vSRX Virtual Firewall that delivers various features of physical firewalls; Spotlight Secure Threat Intelligence Platform, a threat intelligence platform that aggregates threat feeds from various sources; and Sky Advanced Threat Prevention, a cloud-based service for static and dynamic analysis. Further, the company offers Junos OS, a network operating system; Junos Space, a network management platform for creating network management applications that include network director, services activation director, security director, edge services director, service now, and service insight; and Contrail networking and cloud platform solutions. Additionally, it provides technical support and professional services, as well as education and training programs. The company sells its products through direct sales, distributors, value-added resellers, and original equipment manufacturer partners to end-users in the service provider and enterprise markets. Juniper Networks, Inc. was founded in 1996 and is headquartered in Sunnyvale, California.

Amgen Inc. (AMGN) continued its downward trend with the stock declining -1.35% or $-2.14 to close the day at $156.62 on active trading volume of 4.79M shares, compared to its three month average trading volume of 4.1M. The Thousand Oaks California 91320 based company has been outperforming the biotechnology group over the past 52 weeks, with the stock gaining 6.6%, compared to the industry which has advanced 0.66% over the same period. With RSI of 64.83, the stock should still continue to rise and get closer to its one year target estimate of $179.98, making it a hold for now.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company’s products include Neulasta, a pegylated protein for the treatment of cancer patients; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for reducing the incidence of infection for patients with non-myeloid malignancies; and Enbrel to treat rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis. Its products also comprise EPOGEN to treat a lower-than-normal number of red blood cells caused by chronic kidney disease (CKD) in patients on dialysis; Aranesp for treating anemia; XGEVA for the prevention of skeletal-related events; Prolia to treat postmenopausal women with osteoporosis; Repatha for the treatment of cholesterol; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in CKD patients on dialysis. The company’s other marketed products include Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; Vectibix, a human monoclonal antibody; and BLINCYTO for the treatment of patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It also develops various products that are in various clinical trials. The company serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. It has collaborative agreements with Xencor, Inc; UCB; Novartis AG; Bayer HealthCare Pharmaceuticals Inc; Advaxis, Inc.; Dr. Reddy’s Laboratories Ltd.; Biocartis Group NV; and Nuevolution AB. The company also has a strategic collaboration with Immatics Biotechnologies GmbH. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

The Charles Schwab Corporation (SCHW) shares were up in last trading by 0.32% to $41.32. It experienced lighter than average volume on day. The stock increased in value by almost 0.24% over the past week and grew 5.09% in the past month. It is currently trading 9.49% above its 50 day moving average and 32.05% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -0.48% decrease in value from its one year high of $41.52. The RSI indicator value of 68.28, lead us to believe that it is a hold for now.

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; and stock plan services, compliance solutions, and mutual fund clearing services, as well as engages in the off-platform sales business. The Advisor Services segment provides custodial, trading, and support services; and retirement and corporate brokerage retirement services. The company provides brokerage accounts with cash management capabilities; third-party mutual funds through the Mutual Fund Marketplace, including no-transaction fee mutual funds through the Mutual Fund OneSource service, which includes proprietary mutual funds, plus mutual fund trading, and clearing services to broker-dealers; exchange-traded funds (ETFs), including proprietary and third-party ETFs; and advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. It also offers banking products and services, including checking and savings accounts, certificates of deposit, first lien residential real estate mortgage loans, home equity loans and lines of credit, and Pledged Asset Lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. The company serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

 

3 Stocks to Watch For: The Charles Schwab Corporation (SCHW), SUPERVALU Inc. (SVU), Marathon Petroleum Corporation (MPC)

The Charles Schwab Corporation (SCHW) saw its value increase by 0.17% as the stock gained $0.07 to finish the day at a closing price of $41.19. The stock was lighter in trading and has fluctuated between $21.51-$41.52 per share for the past year. The shares, which traded within a range of $40.99 to $41.49 during the day, are up by 27.21% in the past three months and up by 54.62% over the past six months. It is currently trading 3.27% above its 20 day moving average and 9.67% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $41.33 a share over the next twelve months. The current relative strength index (RSI) reading is 68.57.The technical indicator lead us to believe there will be no major movement any time soon, hold.

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; and stock plan services, compliance solutions, and mutual fund clearing services, as well as engages in the off-platform sales business. The Advisor Services segment provides custodial, trading, and support services; and retirement and corporate brokerage retirement services. The company provides brokerage accounts with cash management capabilities; third-party mutual funds through the Mutual Fund Marketplace, including no-transaction fee mutual funds through the Mutual Fund OneSource service, which includes proprietary mutual funds, plus mutual fund trading, and clearing services to broker-dealers; exchange-traded funds (ETFs), including proprietary and third-party ETFs; and advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. It also offers banking products and services, including checking and savings accounts, certificates of deposit, first lien residential real estate mortgage loans, home equity loans and lines of credit, and Pledged Asset Lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. The company serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

SUPERVALU Inc. (SVU) shares were up in last trading by 2.35% to $4.79. It experienced higher than average volume on day. The stock increased in value by almost 3.01% over the past week and fell -3.23% in the past month. It is currently trading 1.8% above its 50 day moving average and -2.47% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -22.37% decrease in value from its one year high of $6.17. The RSI indicator value of 50.21, lead us to believe that it is a hold for now.

SUPERVALU INC., together with its subsidiaries, operates as a grocery wholesaler and retailer in the United States. The company operates through three segments: Wholesale, Save-A-Lot, and Retail. The Wholesale segment offers wholesale distribution of various food and non-food products to independent retail customers, such as single and multiple grocery store independent operators, regional chains, and the military. This segment operates approximately 1,796 stores with a network spanning 40 states. The Save-A-Lot segment owns, operates, and licenses 1,360 discount grocery stores under the Save-A-Lot banner, including 897 licensed Save-A-Lot stores and 463 company-operated stores. The Retail segment operates retail stores that provide groceries and various additional products, including general merchandise, home, health and beauty care, and pharmacy products. This segment operates 200 stores under the Cub Foods, Shoppers Food & Pharmacy, Shop ’n Save, Farm Fresh, and Hornbacher’s banners, as well as 2 Rainbow and 2 County Market stores. The company provides a range of brand name and private-label products comprising perishable and nonperishable grocery products. SUPERVALU INC. was founded in 1871 and is headquartered in Eden Prairie, Minnesota.

Marathon Petroleum Corporation (MPC) traded within a range of $48.97 to $49.96 after opening the day at $49.5. The company has seen its stock decrease in value by -2.74% so far this year. The stock was down close to -0.99% on light volume in last trading session and closed at $48.97 per share. After the recent fall, the stock is currently holding -10.29% below its 52 week high of $54.59 and 73.68% above its 12-month low of $29.24. The shares are up by over 16.26% in the last three months, and the RSI indicator value of 48.99 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Marathon Petroleum Corporation, together with its subsidiaries, engages in refining, marketing, retailing, and transporting petroleum products primarily in the United States. It operates through three segments: Refining & Marketing, Speedway, and Midstream. The company refines crude oil and other feed stocks at its seven refineries in the Gulf Coast and Midwest regions of the United States; and purchases ethanol and refined products for resale. Its refined products include gasoline, distillates, propane, feed stocks and special products, heavy fuel oil, and asphalt. The company also sells transportation fuels and convenience products in the retail market through Speedway convenience stores; and transports crude oil and other feed stocks to its refineries and other locations. Marathon Petroleum Corporation markets its refined products to resellers, consumers, independent retailers, wholesale customers, marathon-branded independent entrepreneurs, its Speedway convenience stores, airlines, transportation companies, and utility companies, as well as exports its refined products. As of December 31, 2015, it owned, leased, and had ownership interests in approximately 8,400 miles of crude oil and refined product pipelines, as well as owned and operated 2,766 gasoline and convenience stores in 22 states of the United States; and had 5,600 retail outlets operated by independent entrepreneurs in 19 states in the United States. The company was incorporated in 2009 and is headquartered in Findlay, Ohio.

 

Stocks in Review: The Charles Schwab Corporation (SCHW), Opko Health, Inc. (OPK), HCP, Inc. (HCP)

The Charles Schwab Corporation (SCHW) traded within a range of $40.64 to $41.25 after opening the day at $41. The company has seen its stock increase in value by 4.18% so far this year. The stock was down close to -0.27% on light volume in last trading session and closed at $41.12 per share. After the recent fall, the stock is currently holding -0.96% below its 52 week high of $41.52 and 92.51% above its 12-month low of $21.51. The shares are up by over 27.19% in the last three months, and the RSI indicator value of 68.99 is neither bullish nor bearish, tempting investors to stay on the sidelines.

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; and stock plan services, compliance solutions, and mutual fund clearing services, as well as engages in the off-platform sales business. The Advisor Services segment provides custodial, trading, and support services; and retirement and corporate brokerage retirement services. The company provides brokerage accounts with cash management capabilities; third-party mutual funds through the Mutual Fund Marketplace, including no-transaction fee mutual funds through the Mutual Fund OneSource service, which includes proprietary mutual funds, plus mutual fund trading, and clearing services to broker-dealers; exchange-traded funds (ETFs), including proprietary and third-party ETFs; and advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. It also offers banking products and services, including checking and savings accounts, certificates of deposit, first lien residential real estate mortgage loans, home equity loans and lines of credit, and Pledged Asset Lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. The company serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

Opko Health, Inc. (OPK) failed to extend gains with the stock declining -0.75% or $-0.07 to close the day at $9.31 on light trading volume of 4.41M shares, compared to its three month average trading volume of 4.53M. The Miami Florida 33137 based company has been outperforming the biotechnology group over the past 52 weeks, with the stock gaining 5.56%, compared to the industry which has advanced 0.02% over the same period. With RSI of 37.26, the stock should still continue to rise and get closer to its one year target estimate of $15.5, making it a hold for now.

OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States, Ireland, Chile, Spain, Israel, and Mexico. Its diagnostics business operates Bio-Reference Laboratories, a clinical laboratory that offers comprehensive laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units. The Bio-Reference Laboratories also provides core genetic testing and leverages products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. The company’s pharmaceutical segment features Rayaldee, a treatment for secondary hyperparathyroidism in stage 3-4 chronic kidney disease patients with vitamin D deficiency and VARUBI for chemotherapy-induced nausea and vomiting. Its biologics business engages in developing and commercializing hGH-CTP, a recombinant human growth hormone product under development for the treatment of growth hormone deficiency, and developing Factor VIIa drug for hemophilia using the carboxl terminal peptide technology. The company was incorporated in 1991 and is headquartered in Miami, Florida.

HCP, Inc. (HCP) dropped $-0.41 to close the day at a new closing price of $30.81, a -1.31% decrease in value from its previous closing price that moved the stock 40.72% above its 52 week low of $22.87. A total of 4.37M shares exchanged hands during the day compared with its three month average trading volume of 4.22M. The stock, which fluctuated between $30.81 and $31.35 during the day, currently situated -15.29% below its 52 week high. The stock is up by 2.26% in the past one month and down by -4.63% over the past three months. With a one year target estimate of $30.08 and RSI of 58.86, the stock still has upside potential, making it a hold for now.

HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. It primarily invests in properties serving the healthcare industry including sectors of healthcare such as senior housing, life science, medical office, hospital and skilled nursing. The fund also invests in mezzanine loans and other debt instruments. It engages in acquisition, development, leasing, selling and managing of healthcare real estate and provides mortgage and other financing to healthcare providers. The fund benchmarks the performance of its portfolio against the S&P 500 Index, Berkshire Hathaway Index, and MSCI REIT Index. HCP, Inc. was formed in 1985 and is based in Irvine, California with additional office in Nashville and San Francisco.

 

3 Notable Runners: The Charles Schwab Corporation (SCHW), American International Group, Inc. (AIG), W&T Offshore, Inc. (WTI)

The Charles Schwab Corporation (SCHW) managed to rebound with the stock climbing 0.63% or $0.26 to close the day at $41.23 on lower than average trading volume of 5.64M shares, compared to its three month average trading volume of 9.32M. The San Francisco California 94105 based company has been outperforming the investment brokerage – national companies by 27.1072% for last three months and its recent gains have pushed the stock slightly up 4.46% YTD, versus the investment brokerage – national industry which is up 3.5% for the same period. The RSI of 70.17 indicates the stock is overbought at the current levels, sell for now.

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; and stock plan services, compliance solutions, and mutual fund clearing services, as well as engages in the off-platform sales business. The Advisor Services segment provides custodial, trading, and support services; and retirement and corporate brokerage retirement services. The company provides brokerage accounts with cash management capabilities; third-party mutual funds through the Mutual Fund Marketplace, including no-transaction fee mutual funds through the Mutual Fund OneSource service, which includes proprietary mutual funds, plus mutual fund trading, and clearing services to broker-dealers; exchange-traded funds (ETFs), including proprietary and third-party ETFs; and advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. It also offers banking products and services, including checking and savings accounts, certificates of deposit, first lien residential real estate mortgage loans, home equity loans and lines of credit, and Pledged Asset Lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. The company serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

American International Group, Inc. (AIG) had a light trading with around 5.6M shares changing hands compared to its three month average trading volume of 6.03M. The stock traded between $66.19 and $67.08 before closing at the price of $66.81 with 1.84% change on the day. The New York New York 10038 based company is currently trading 39.46% above its 52 week low of $48.41 and -0.33% below its 52 week high of $67.08. Both the RSI indicator and target price of 66.13 and $68.5 respectively, lead us to believe that it should be put on hold over the coming weeks.

American International Group, Inc. provides insurance products and services for commercial, institutional, and individual customers in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. The company operates through two segments, Commercial Insurance and Consumer Insurance. The company’s Commercial Insurance segment offers general liability, commercial automobile liability, workers’ compensation, excess casualty, and crisis management causality insurance products, as well as various risk-sharing and other customized structured programs; commercial, industrial, and energy-related property insurance products; aerospace, environmental, political risk, trade credit, surety, and marine insurance products; various insurance products for small and medium sized enterprises; and professional liability insurance products. It also provides mortgage guaranty insurance; stable value wrap products, and structured settlement and terminal funding annuities; and corporate- and bank-owned life insurance and guaranteed investment contracts. This segment sells its products through independent retail and wholesale brokers, agency network, specialized marketing and consulting firms, and structured settlement brokers. Its Consumer Insurance segment offers retirement products, such as fixed annuities, and immediate and deferred income annuities; variable and fixed index annuities; and mutual funds, and plan administrative and compliance services. This segment’s products also include term and whole life, cancer, and critical illness insurance products; personal accident and supplemental health products; travel insurance products and services; automobile and homeowners, and extended warranty insurance; and identity theft and credit card protection products. It sells its products through agents, direct marketing, independent marketing organizations, financial advisors, banks, wirehouses, and broker-dealers. The company was founded in 1919 and is based in New York, New York.

W&T Offshore, Inc. (WTI) traded within a range of $2.96 to $3.22 after opening the day at $3.01. The company has seen its stock increase in value by 15.16% so far this year. The stock was up close to 9.62% on active volume in last trading session and closed at $3.19 per share. After the recent gain, the stock is currently holding -8.86% below its 52 week high of $3.5 and 159.35% above its 12-month low of $1.23. The shares are up by over 93.33% in the last three months, and the RSI indicator value of 75.75 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.

W&T Offshore, Inc., an independent oil and natural gas producer, engages in the acquisition, exploration, and development of oil and natural gas properties in the Gulf of Mexico. The company sells crude oil, natural gas liquids, and natural gas. It holds working interests in approximately 54 offshore fields in federal and state waters. As of March 8, 2016, the company had interests in offshore leases covering approximately 900,000 gross acres, including approximately 550,000 gross acres in the Gulf of Mexico Shelf; and approximately 350,000 gross acres in the deepwater. It also has a total proved reserves of 76.4 million barrels of oil equivalent. The company was founded in 1983 and is headquartered in Houston, Texas.

 

Stocks in Review: Devon Energy Corporation (DVN), The Charles Schwab Corporation (SCHW), Twenty-First Century Fox, Inc. (FOXA)

Devon Energy Corporation (DVN) traded within a range of $47.67 to $49.45 after opening the day at $47.73. The company has seen its stock increase in value by 7.31% so far this year. The stock was up close to 3.18% on active volume in last trading session and closed at $49.01 per share. After the recent gain, the stock is currently holding -3.19% below its 52 week high of $50.69 and 175.34% above its 12-month low of $18.07. The shares are up by over 11.07% in the last three months, and the RSI indicator value of 66.54 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Devon Energy Corporation, an independent energy company, primarily engages in the exploration, development, and production of oil, natural gas, and natural gas liquids (NGLs) in the United States and Canada. It operates approximately 19,000 wells. The company also offers midstream energy services, including gathering, transmission, processing, fractionation, and marketing to producers of natural gas, NGLs, crude oil, and condensate through its natural gas pipelines, plants, and treatment facilities. Devon Energy Corporation was founded in 1971 and is headquartered in Oklahoma City, Oklahoma.

The Charles Schwab Corporation (SCHW) failed to extend gains with the stock declining -0.61% or $-0.25 to close the day at $40.97 on light trading volume of 6.34M shares, compared to its three month average trading volume of 9.38M. The San Francisco California 94105 based company has been outperforming the investment brokerage – national group over the past 52 weeks, with the stock gaining 34.34%, compared to the industry which has advanced 34.54% over the same period. With RSI of 69.46, the stock should still continue to rise and get closer to its one year target estimate of $40.67, making it a hold for now.

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; and stock plan services, compliance solutions, and mutual fund clearing services, as well as engages in the off-platform sales business. The Advisor Services segment provides custodial, trading, and support services; and retirement and corporate brokerage retirement services. The company provides brokerage accounts with cash management capabilities; third-party mutual funds through the Mutual Fund Marketplace, including no-transaction fee mutual funds through the Mutual Fund OneSource service, which includes proprietary mutual funds, plus mutual fund trading, and clearing services to broker-dealers; exchange-traded funds (ETFs), including proprietary and third-party ETFs; and advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. It also offers banking products and services, including checking and savings accounts, certificates of deposit, first lien residential real estate mortgage loans, home equity loans and lines of credit, and Pledged Asset Lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. The company serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

Twenty-First Century Fox, Inc. (FOXA) dropped $-0.02 to close the day at a new closing price of $29, a -0.07% decrease in value from its previous closing price that moved the stock 29.66% above its 52 week low of $22.66. A total of 6.33M shares exchanged hands during the day compared with its three month average trading volume of 11.15M. The stock, which fluctuated between $28.65 and $29.17 during the day, currently situated -6.49% below its 52 week high. The stock is up by 5.22% in the past one month and up by 17.6% over the past three months. With a one year target estimate of $31.44 and RSI of 61.93, the stock still has upside potential, making it a hold for now.

Twenty-First Century Fox, Inc., together with its subsidiaries, operates as a diversified media and entertainment company in the United States, the United Kingdom, Continental Europe, Asia, Latin America, and internationally. It operates through Cable Network Programming; Television; Filmed Entertainment; and Other, Corporate and Eliminations segments. The company produces and licenses news, sports, movie, and general and factual entertainment programming for distribution primarily through cable television systems, direct broadcast satellite operators, telecommunications companies, and online video distributors. It also broadcasts network programming; and operates 28 broadcast television stations, including 11 duopolies in the United States. In addition, the company produces and acquires live-action and animated motion pictures for distribution and licensing in various formats and entertainment media, as well as produces and licenses television programming worldwide. Further, it offers video advertising services, including consumer engagement and on-demand marketing campaigns; and operates two San Francisco-Bay area television stations. The company was formerly known as News Corporation. Twenty-First Century Fox, Inc. was founded in 1922 and is headquartered in New York, New York.

 

3 Stocks in Focus: The Charles Schwab Corporation (SCHW), Corning Incorporated (GLW), Hilton Worldwide Holdings Inc. (HLT)

The Charles Schwab Corporation (SCHW) climbed 1.85% during last trading as the stock added $0.73 to finish the day at $40.2 with about 6.95M shares changing hands, compared to its three month average trading volume of 9.37M. The $53.44B market cap company, which fluctuated between $39.72 and $40.65 during the day, currently situated 88.2% above its 52 week low of $21.51 and -0.94% away from its one year high of $40.65. The RSI of 66 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, money management, custody, and financial advisory services. The company operates through two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage and banking services, retirement plan services, and other corporate brokerage services; and stock plan services, compliance solutions, and mutual fund clearing services, as well as engages in the off-platform sales business. The Advisor Services segment provides custodial, trading, and support services; and retirement and corporate brokerage retirement services. The company provides brokerage accounts with cash management capabilities; third-party mutual funds through the Mutual Fund Marketplace, including no-transaction fee mutual funds through the Mutual Fund OneSource service, which includes proprietary mutual funds, plus mutual fund trading, and clearing services to broker-dealers; exchange-traded funds (ETFs), including proprietary and third-party ETFs; and advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. It also offers banking products and services, including checking and savings accounts, certificates of deposit, first lien residential real estate mortgage loans, home equity loans and lines of credit, and Pledged Asset Lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. The company serves individuals and institutional clients in the United States, the Commonwealth of Puerto Rico, London, and Hong Kong. The Charles Schwab Corporation was founded in 1971 and is headquartered in San Francisco, California.

Corning Incorporated (GLW) gained $0.03 to close the day at a new closing price of $24.3, a 0.12% increase in value from its previous closing price that moved the stock 54.58% above its 52 week low of $16.13. A total of 6.86M shares exchanged hands during the day compared with its three month average trading volume of 8.05M. The stock, which fluctuated between $24.12 and $24.53 during the day, currently situated -4.14% below its 52 week high. The stock is up by 3.27% in the past one month and up by 3.3% over the past three months. With a one year target estimate of $23.28 and RSI of 53.33, the stock still has upside potential, making it a hold for now.

Corning Incorporated manufactures and sells specialty glasses, ceramics, and related materials worldwide. The company operates through five segments: Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, and Life Sciences. The Display Technologies segment manufactures glass substrates for liquid crystal displays (LCDs) used in LCD televisions, notebook computers, and flat panel desktop monitors. The Optical Communications segment manufactures optical fiber and cable; and hardware and equipment products comprising cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories. This segment also offers subscriber demarcation, connection and protection devices, passive solutions, and outside plant enclosures; and coaxial RF interconnects for the cable television industry and microwave applications. The Environmental Technologies segment manufactures ceramic substrates and filter products for emissions control in mobile and stationary, and gasoline and diesel applications. The Specialty Materials segment manufactures products that provide approximately 150 material formulations for glass, glass ceramics, and fluoride crystals. The Life Sciences segment manufactures and supplies scientific laboratory products consisting of consumables, such as plastic vessels, specialty surfaces, and media, as well as general labware and equipment for cell culture research, bioprocessing, genomics, drug discovery, microbiology, and chemistry. It also engages in a pharmaceutical glass vessel and a tubing business; and precision materials’ non-LCD business, as well as precision laser cutting/shaping technologies, and flow reactors and adjacency businesses for glass. The company was formerly known as Corning Glass Works and changed its name to Corning Incorporated in April 1989. Corning Incorporated was founded in 1851 and is headquartered in Corning, New York.

Hilton Worldwide Holdings Inc. (HLT) had a light trading with around 6.83M shares changing hands compared to its three month average trading volume of 9.4M. The stock traded between $27 and $27.62 before closing at the price of $27.39 with 0.7% change on the day. The McLean Virginia 22102 based company is currently trading 71.62% above its 52 week low of $16.16 and -2% below its 52 week high of $27.95. Both the RSI indicator and target price of 66.56 and $30.02 respectively, lead us to believe that it should be put on hold over the coming weeks.

Hilton Worldwide Holdings Inc., a hospitality company, owns, leases, manages, develops, and franchises hotels, resorts, and timeshare properties worldwide. The company operates through three segments: Ownership, Management and Franchise, and Timeshare. It also licenses its brands to franchisees; provides hotel management services for third parties; and markets and sells timeshare interests owned by Hilton and third parties. In addition, the company provides consumer financing, which includes interest income generated from the origination of consumer loans to finance their purchase of timeshare intervals. It operates hotels under the Waldorf Astoria Hotels & Resorts, Conrad Hotels & Resorts, Canopy by Hilton, Hilton Hotels & Resorts, Curio – A Collection by Hilton, DoubleTree by Hilton, Embassy Suites by Hilton, Hilton Garden Inn, Hampton by Hilton, Tru by Hilton, Homewood Suites by Hilton, Home2 Suites by Hilton, Hilton Grand Vacations, and Hampton Inn brands. As of December 29, 2016, the company had approximately 4,800 managed, franchised, owned, and leased hotels, resorts, and timeshare properties comprising 789,000 rooms in 104 countries and territories. Hilton Worldwide Holdings Inc. was founded in 1919 and is headquartered in McLean, Virginia.